BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27764786)

  • 1. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
    Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
    Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.
    Chen LJ; Sun J; Wu HY; Zhou SM; Tan Y; Tan M; Shan BE; Lu BF; Zhang XG
    Cancer Immunol Immunother; 2011 Jul; 60(7):1047-55. PubMed ID: 21519829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.
    Mizuno T; Kamai T; Tsuzuki T; Nishihara D; Kijima T; Arai K; Yoshida KI
    Cancer Immunol Immunother; 2022 Mar; 71(3):565-578. PubMed ID: 34275008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of B7-H4 is associated with infiltrating immune cells and poor prognosis in metastatic colorectal cancer.
    Ding S; Lv X; Liu Z; Zhan S; Xu Y; Zhang X; Liu C; Cao L
    Int Immunopharmacol; 2021 Jan; 90():107144. PubMed ID: 33187907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer.
    Yang J; Tian Z; Gao H; Xiong F; Cao C; Yu J; Shi W; Zhan Q; Yang C
    BMC Cancer; 2022 May; 22(1):584. PubMed ID: 35624419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes.
    Kim NI; Park MH; Cho N; Lee JS
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):246-256. PubMed ID: 35384874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B7-H4 in endometrial cancer and its impact on patients' prognosis.
    Gorzelnik K; Wasaznik-Jedras A; Wicherek L; Szubert S
    Ginekol Pol; 2024; 95(4):252-258. PubMed ID: 37873922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis.
    Qin X; Sun W; Wang C; Li M; Zhao X; Li C; Zhang H
    Reprod Biol Endocrinol; 2021 Jul; 19(1):114. PubMed ID: 34289871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.
    Jiang J; Zhu Y; Wu C; Shen Y; Wei W; Chen L; Zheng X; Sun J; Lu B; Zhang X
    Cancer Immunol Immunother; 2010 Nov; 59(11):1707-14. PubMed ID: 20725832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression characteristics and clinical significance of B7-H3 in colorectal cancer].
    Shao Y; Shi T; Guo L; Chen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):435-442. PubMed ID: 38790100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma.
    Sun J; Chen LJ; Zhang GB; Jiang JT; Zhu M; Tan Y; Wang HT; Lu BF; Zhang XG
    Cancer Immunol Immunother; 2010 Aug; 59(8):1163-71. PubMed ID: 20333377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.
    Che F; Heng X; Zhang H; Su Q; Zhang B; Chen Y; Zhang Z; Du Y; Wang L
    Cancer Immunol Immunother; 2017 Jun; 66(6):717-729. PubMed ID: 28246881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H4 Further Stratifies Patients With Endometrial Cancer Exhibiting a Nonspecific Molecular Profile.
    Zong L; Yu S; Mo S; Sun Z; Lu Z; Chen J; Xiang Y
    Arch Pathol Lab Med; 2023 Nov; 147(11):1288-1297. PubMed ID: 36669510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
    Sousa LG; McGrail DJ; Lazar Neto F; Li K; Marques-Piubelli ML; Ferri-Borgogno S; Dai H; Mitani Y; Spardy Burr N; Cooper ZA; Kinneer K; Cortez MA; Lin SY; Bell D; El Naggar A; Burks J; Ferrarotto R
    Clin Cancer Res; 2023 Aug; 29(16):3162-3171. PubMed ID: 37256648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of inhibitory B7 family members in Alzheimer's disease.
    Sabaie H; Tamimi P; Gharesouran J; Salkhordeh Z; Asadi MR; Sharifi-Bonab M; Shirvani-Farsani Z; Taheri M; Sayad A; Rezazadeh M
    Metab Brain Dis; 2023 Dec; 38(8):2563-2572. PubMed ID: 37665469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of B7 family molecules in hematologic malignancy.
    Greaves P; Gribben JG
    Blood; 2013 Jan; 121(5):734-44. PubMed ID: 23223433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-phase trans-ethnic study reveals
    Gao Y; Xu Y; Gao M; Huang A; Chi P
    J Gastrointest Oncol; 2021 Dec; 12(6):2891-2905. PubMed ID: 35070416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features and prognostic value of CD276 expression in breast cancer: A meta-analysis.
    Su H; Lin X; Huo J; Zhang F
    Asian J Surg; 2023 Nov; 46(11):5323-5329. PubMed ID: 37543458
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody-Drug Conjugates: Advancing from Magic Bullet to Biological Missile.
    Veneziani AC; Sneha S; Oza AM
    Clin Cancer Res; 2024 Apr; 30(8):1434-1437. PubMed ID: 38306232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of B7-H4 in non-small cell lung cancer.
    Wang W; Xu C; Wang Y; Yu L; Zhang X
    Biomarkers; 2016 Jun; ():1-16. PubMed ID: 27321138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.